Enhancement of Physical Fitness in Older Adults (NLC2010)
|ClinicalTrials.gov Identifier: NCT01421628|
Recruitment Status : Completed
First Posted : August 23, 2011
Last Update Posted : August 23, 2011
|Condition or disease||Intervention/treatment|
|Pain Physical Impairment||Other: Fitness exercise program|
The ageing population leads to an increase of chronic disease and disability and to a decrease of physical activity and ADL performance. This circle can be reversed by physical exercise to increase physical fitness.
The goal of this research is to establish the effects of a trainings program on ADL performance, physical fitness and nocturnal cramps. Furthermore the characteristics from participants who benefit from the program will be investigated by the research.
The study design is a randomized intervention study. Participants are elderly people, age 65 years and older, without cognitive impairment.
Intervention: The intervention is a physical trainings program. The intensity is moderate, the frequency is daily and the total duration is 6 weeks. The control group will be provided with an education program.
Main parameters are: physical fitness, nocturnal cramp severity and frequency.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||180 participants|
|Intervention Model:||Factorial Assignment|
|Official Title:||The Effectiveness of a Trainings Program on ADL Performance, Physical Fitness, Wellbeing, and Nocturnal Cramp in Elderly People|
|Study Start Date :||September 2010|
|Primary Completion Date :||November 2010|
|Study Completion Date :||November 2010|
Other: Fitness exercise program
Exercise program, daily frequency, duration of 6 weeks.
- Physical fitness [ Time Frame: six weeks ]Strength, balance
- ADL performance [ Time Frame: six weeks ]Performance based ADL test
- Well being [ Time Frame: six weeks ]Questionnaires like SF-36
- Nocturnal cramps [ Time Frame: Six weeks ]Visual analogue scale (VAS)
- Frequency nocturnal cramp [ Time Frame: Six weeks ]Number of cramp attacks per day.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01421628
|Appingedam, Groningen, Netherlands, 9934 JD|
|Principal Investigator:||Hank Hallegraeff, PT, MSc|